RESUMO
Acute pancreatitis is associated with significant morbidity and mortality. It can develop complications such as fluid collections and necrosis. Infection of necrosis occurs in about 20-40 % of patients with severe acute pancreatitis, and is associated with organ failure and worse prognosis. In the past few years the treatment of pancreatic collections has shifted from open surgery to minimally invasive techniques such as endoscopic ultrasound-guided drainage. These guidelines from a selection of experts among the Endoscopic Ultrasound Group, Spanish Society of Gastrointestinal Endoscopy (GSEED-USE) are intended to provide advice on the management of pancreatic collections based on a thorough review of the available scientific evidence. It also reflects the experience and clinical practice of the authors, who are advanced endoscopists or clinical pancreatologists with extensive experience in managing patients with acute pancreatitis.
Assuntos
Endossonografia , Pancreatite , Humanos , Endossonografia/métodos , Pancreatite/diagnóstico por imagem , Pancreatite/terapia , Drenagem/métodos , Endoscopia do Sistema Digestório/métodos , EspanhaRESUMO
BACKGROUND: Lumen apposing metal stent (LAMS) allows an easy access to peripancreatic fluid collections (PPFCs) and the possibility of performing direct endoscopic necrosectomy (DEN). The aim of our study was to evaluate the safety and efficacy of a new 20-mm LAMS in the management of PPFCs. This novel stent represents the largest diameter LAMS available on the market to date. METHODS: This is an international, multicenter retrospective study involving 20 centers. Consecutive patients who underwent EUS-guided PPFC drainage using a 20-mm LAMS were included. Primary outcomes were technical and clinical success. Secondary outcomes were rate and the severity of adverse events. RESULTS: A total 105 patients underwent PPFC drainage using the new 20-mm LAMS and 106 LAMS were placed. Technical success was 100% (106/106). 7/105 patients died due to causes not related to the stent. Clinical success was achieved in 92/98 patients (93.9%). Significant adverse events occurred in 8/98 patients (8.16%): 4 cases (4.08%) of bleeding, 3 cases (3.06%) of suprainfection, 1 case of gastric outlet obstruction. CONCLUSIONS: This multicenter study demonstrated acceptable rates of technical and clinical success using a new 20-mm LAMS for PPFC, including walled-off pancreatic necrosis (WOPN). The results of our study suggest that a new 20-mm LAMS is non-inferior in terms of safety, efficacy, and adverse events as compared to smaller diameter LAMS in the management of PPFCs, including pancreatic psuedocysts (PP) and WOPN. Randomized controlled studies will be needed to determine the ideal size of LAMS need to achieve the greatest clinical benefit with the minimized risk exposure for this high-risk patient population.
Assuntos
Líquidos Corporais/química , Endoscopia , Internacionalidade , Pâncreas/patologia , Pâncreas/cirurgia , Stents/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Drenagem , Endossonografia , Hemorragia/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Pâncreas/diagnóstico por imagem , Estudos Retrospectivos , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Delayed gastrointestinal (GI) bleeding and stent migration are known adverse events which may occur following placement of lumen-apposing metal stents (LAMSs). METHODS: All consecutive patients who underwent LAMS placement between May 2011 and June 2017âat a single tertiary medical center were included. Demographics and procedural details were prospectively collected. Post-procedure follow-up and outcome measures were retrospectively collected. The cumulative risks of migration and LAMS-related GI bleeding were estimated using the life-table method. Risk predictors were assessed using Cox proportional hazards models. RESULTS: We analyzed 250 patients (64.8â% men; median age 71.6 [interquartile range (IQR) 57.9â-â83.6]). Median follow-up was 78.5 days (IQR 31â-â246.5 days). Thirty-four stent migrations (13.6â%) occurred (5 symptomatic). On multivariable analysis, associations with migration included nasocystic drains (hazard ratio [HR] 6.5, 95â% confidence interval [CI] 2.2â-â19.3), pancreatic fluid collections (PFCs; HR 4.2, 95â%CI 1.8â-â10.1), and double-pigtail stents (HR 2.4, 95â%CI 1.2â-â4.9). Migration risk at 12 months was 25.5â% (95â%CI 17.9â%â-â35.7â%) and was higher for PFCs 48.9â% (33.4â%â-â66.9â%) than other indications 8.4â% (4.9â%â-â17.5â%; Pâ<â0.001). LAMSs placed for longer durations (i.âe. enteral anastomoses, biliary and gallbladder drainage) presented an 8.4â% cumulative risk at 2 years. There were 13 LAMS-related GI hemorrhages (5.2â%), two of them fatal, presenting a median of 3 days (IQR 1â-â9 days) after deployment. The cumulative risk of bleeding at 12 months was 6.9â% (3.6â%â-â12.7â%). CONCLUSIONS: LAMS migration occurs in 1 out of 7 cases and is most common when treating PFCs. Bleeding related to LAMS placement occurs much less commonly but can be life-threatening.
Assuntos
Hemorragia Gastrointestinal/etiologia , Falha de Prótese/etiologia , Stents/efeitos adversos , Idoso , Idoso de 80 Anos ou mais , Drenagem/efeitos adversos , Desenho de Equipamento/efeitos adversos , Feminino , Seguimentos , Humanos , Masculino , Metais , Pessoa de Meia-Idade , Pancreatopatias/complicações , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Fatores de TempoRESUMO
Granular cell tumor (GCT) is a rare neoplasm that develops in the gut's submucosal layer. We report the case of a male with a history of surgically excised colon neoplasm where a rectal polyp was identified during a follow-up endoscopy. The lesion, eventually identified as a GCT, was endoscopically removed by band ligation-assisted mucosectomy. This may be the second report of a colorectal GCT successfully managed using band ligation, and the first one on a rectal GCT excised with this technique.
Assuntos
Endoscopia Gastrointestinal/métodos , Tumor de Células Granulares/cirurgia , Neoplasias Retais/cirurgia , Endoscopia do Sistema Digestório , Tumor de Células Granulares/diagnóstico por imagem , Humanos , Ligadura , Masculino , Pessoa de Meia-Idade , Neoplasias Retais/diagnóstico por imagem , Resultado do TratamentoRESUMO
El tumor de células granulares (TCG) es un tumor raro que se localiza en la capa submucosa del tubo digestivo. Presentamos a continuación a un varón con antecedentes de neoplasia de colon extirpada mediante cirugía en el que durante una colonoscopia de control se identificó un pólipo en el recto que extirpamos endoscópicamente realizando una mucosectomia asistida con banda elástica, resultando ser un TCG. Estamos ante lo que puede ser la segunda publicación de un TCG colorrectal tratado con éxito mediante banda elástica y el primer caso de TCG extirpado en el recto con esta técnica (AU)
Granular cell tumor (GCT) is a rare neoplasm that develops in the guts submucosal layer. We report the case of a male with a history of surgically excised colon neoplasm where a rectal polyp was identified during a follow-up endoscopy. The lesion, eventually identified as a GCT, was endoscopically removed by band ligation-assisted mucosectomy. This may be the second report of a colorectal GCT successfully managed using band ligation, and the first one on a rectal GCT excised with this technique (AU)